Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03225729
Other study ID # 2017-A02179-44
Secondary ID
Status Completed
Phase N/A
First received July 20, 2017
Last updated January 3, 2018
Start date October 25, 2017
Est. completion date December 22, 2017

Study information

Verified date January 2018
Source Cryobeauty
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the performance of new technology "CRYOTHERAPY MAINS ET DECOLLETE" against a classic cryotherapy "Nitrogen Liquid " to treat solar lentigines.

The hands and the neckline will be randomised, either left or right side and treated by two cryotherapy devices:

1. CRYOTHERAPY MAINS ET DECOLLETE is the device under evaluation.

2. Liquid nitrogen is a comparator device.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 22, 2017
Est. primary completion date December 22, 2017
Accepts healthy volunteers No
Gender All
Age group 30 Years to 75 Years
Eligibility Inclusion Criteria:

- Phototype II to IV

- Presenting solar lentigos on both hands and neck, diameter = 6mm

- Accepting not to expose the body to sunlight or artificial UV rays during the study

- Affiliate to a health insurance plan

- Having undergone a general clinical examination attesting to his / her ability to participate in the study

- Having given written consent

Exclusion Criteria:

- Having carried out aesthetic care (exfoliants, scrubs or self-tanning, manicure, hand care, UV ...) in the month before the start of the study, at the level of the hands and/or neckline.

- Having applied a depigmenting product in the month preceding the start of the study, at the level of the hands and/or neckline.

- Having carried out aesthetic care at a dermatologist (laser, IPL, peeling, depigmenting creams, cryotherapy ...), at the level of the hands and/or neckline, during the last six months

- Dermatosis, autoimmune disease (vitiligo), systemic, chronic or acute disease, or any other disease that may interfere with the treatment or influence the results of the study (people with diabetes, circulatory problems, cold allergies, With Raynaud's syndrome ...)

- Receiving general or local treatment (corticosteroids ...) likely to interfere with the evaluation of the studied parameters.

- Participating in another study or being in an exclusion period from a previous study

- Being incapable of following the requirements of the protocol

- Person protected by law

- Unable to read and write French

- Pregnant woman or woman wishing to be pregnant during the study, or during breastfeeding period

- Women of childbearing age who do not have contraception

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CRYOBEAUTY MAINS ET DECOLLETE
The intervention lasts up to 6.5 s. The device will be applied on spots <6 mm which are previously selected by the investigator team.
Liquid nitrogen
The intervention lasts up to 3 s. The liquid is stored in well-isolated recipients. Each patient has his recipient to avoid contamination. The investigator applies on spots <6 mm a small amount of nitrogen liquid.

Locations

Country Name City State
France CPCAD Nice

Sponsors (2)

Lead Sponsor Collaborator
Cryobeauty CEISO

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance assessment of new cryotherapy device "CRYOTHERAPY MAIN ET DECOLLETE" to treat solar lentigo spots on the hands. Evaluation of CRYOBEAUTY MAINS's performance
Hexsel scoring:
> Very significant clearance (about 90%); only minor evidence of hyper pigmentation remains
> Significant improvement (about 75%); some signs of hyper pigmentation remains
> Intermediate between marked and slight improvement; about 50% improvement in the appearance of hyper pigmentation
> Some improvement (about 25%); however, significant evidence of hyper pigmentation remains
> Hyperpigmentation has not changed since baseline
> Worse (hyperpigmentation is worse than at baseline)
8 weeks
Secondary Performance assessment of CRYOBEAUTY HANDS AND DECOLLETE on the spots of the neckline. Evaluation of CRYOBEAUTY MAINS's performance
Hexsel scoring:
> Very significant clearance (about 90%); only minor evidence of hyper pigmentation remains
> Significant improvement (about 75%); some signs of hyper pigmentation remains
> Intermediate between marked and slight improvement; about 50% improvement in the appearance of hyper pigmentation
> Some improvement (about 25%); however, significant evidence of hyper pigmentation remains
> Hyperpigmentation has not changed since baseline
> Worse (hyperpigmentation is worse than at baseline)
8 weeks
Secondary Evolution of spot's colour Colours assessment: by using Mexameter® MX 18 0 weeks
Secondary Evolution of spot's colour Colours assessment: by using Mexameter® MX 18 4 weeks
Secondary Evolution of spot's colour Colours assessment: by using Mexameter® MX 18 8 weeks
Secondary Pain assessment VAS 0 weeks
Secondary Incidence of Treatment-Emergent Adverse Events Adverse events [Safety and Tolerability] 4 weeks
Secondary Incidence of Treatment-Emergent Adverse Events Adverse events [Safety and Tolerability] 8 weeks
Secondary Assessment of ergonomic and device's readiness Ergonomic and device's readiness questionnaire: 6 QCM questions are given to the participants 0 weeks
Secondary Assessment of volunteers feeling (QoL) MelasQoL (Melasma. Quality of Life Scale) 0 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05886010 - Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins N/A
Active, not recruiting NCT06288607 - Safety and Efficacy of High Intensity Focused Ultrasound in Solar Lentigo: A Self-controlled Study
Recruiting NCT06363240 - Evaluation of Broadband Light Treatment for Solar Lentigines N/A
Completed NCT03157427 - Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers. N/A
Not yet recruiting NCT05883657 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) N/A
Completed NCT05322668 - Tolerance of Cyto-selective Difluoroethane-based Cryotherapy N/A
Completed NCT05203263 - Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept N/A
Recruiting NCT03578315 - Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder N/A
Not yet recruiting NCT06305897 - Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face N/A
Not yet recruiting NCT06361251 - Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face N/A
Completed NCT05625815 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots. N/A